A Phase 1 PK Study of Tolperisone in Healthy Subjects
Clinical trial NCT04465266 · COMPLETED
Trial details
- NCT number
- NCT04465266
- Sponsor
- Neurana Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-28
- Primary completion
- 2020-08-21
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.